Liver cancer on the rise: modifiable risks, stigma, and urgent actions to curb the burden

Source and overview

Author: Liver Cancer UK. This article outlines how liver cancer is rapidly increasing in the UK and worldwide, driven by largely preventable liver disease and risk factors, and stresses the need for urgent action and public awareness.

Key insights:

• Public health strategies are essential to curb rising liver cancer, which is closely linked to preventable liver disease.
• Modifiable factors such as alcohol use, obesity, diabetes, and viral hepatitis are central to prevention and early detection efforts.
• Stigma and lack of awareness hinder early diagnosis and treatment, underscoring the need for better education and accessible screening.
• Policy actions, including advertising restrictions, minimum unit pricing for alcohol, and expanded hepatitis testing and vaccination, are critical to reduce future cases.

Introduction

The article provides a comprehensive look at liver cancer as a rapidly rising cause of cancer-related deaths in the United Kingdom and a leading cause of cancer mortality worldwide. It emphasizes that most liver cancers develop in people with long-term liver disease and cites recent estimates suggesting that around one in three adults worldwide live with some form of liver disease. The piece also notes that while the disease is often mild in early stages, progression to more serious liver damage increases cancer risk, making early action crucial. It underscores that obesity, type 2 diabetes, excess alcohol consumption, and viral hepatitis are among the most common causes of liver disease, and frames rising liver cancer as a consequence of the growing liver disease burden if urgent action is not taken.

Context and scope are set by data indicating liver cancer is among the fastest rising causes of cancer deaths in the UK and the third leading cause worldwide, with more than 6,000 deaths in the UK each year. The article argues that much of the preventable risk can be addressed through lifestyle changes and public health policies, while recognizing that awareness and stigma remain barriers to care and timely diagnosis. It calls for a combination of individual behavior change and government-led policy reform to reverse current trends.

Modifiable risk factors and prevention

The piece highlights that at least 60% of primary liver cancers may be preventable by modifying risk factors. It recommends stopping or significantly reducing alcohol intake, quitting smoking, limiting ultra-processed foods, maintaining a healthy diet, and staying physically active as strategies that benefit the liver and also reduce risks for other cancers and major diseases. It emphasizes that obesity and viral hepatitis are central drivers of liver disease and liver cancer, and that addressing these requires both personal health actions and broader public health measures.

Early action not only benefits liver health but also contributes to reducing the overall burden of cancer and cardiovascular disease. The article also discusses stigma as a barrier that can discourage people from seeking help, delay diagnosis, and influence how health systems prioritize liver disease. It argues for a non-judgmental framing of obesity and viral hepatitis, stressing the importance of healthcare support in improving outcomes.

Context, detection, and screening

The article notes that many people with liver disease and liver cancer are not aware they have the condition in early stages because symptoms often appear later. It underlines that early detection improves survival and is the focus of ongoing research. It encourages conversations with GPs about screening if risk factors are present, including type 2 diabetes, obesity, and regular alcohol consumption, and stresses expanding access to viral hepatitis testing, treatment, and vaccination as essential steps in risk reduction.

Urgent action and policy reforms

Urgent government action and policy reform are presented as necessary to reverse the upward trend. The piece cites evidence-based tools such as restrictions on advertising alcohol and unhealthy foods to children, health warning labels, and taxes on alcohol. It references Scotland’s minimum unit pricing as associated with reductions in alcohol-related deaths, illustrating how policy can have tangible health benefits. It also emphasizes the carcinogenic nature of alcohol and the potential for reducing cancer risk through measures that lower alcohol consumption. The article calls for greater funding for addiction services and community liver health checks, especially for populations facing socioeconomic challenges. It stresses the importance of expanding access to viral hepatitis testing, vaccination, and treatment, noting that current progress toward the WHO goal of eliminating viral hepatitis by 2030 requires intensified action. Finally, it argues for broader prevention and treatment programs, as well as improved risk identification, to reduce future liver cancer cases and alleviate pressure on health systems.

Conclusion

The article closes by drawing a parallel with tobacco control, suggesting that accountability for the alcohol and food industries and comprehensive policy reform are necessary to move from individual responsibility to systemic action. With the right mix of public awareness, policy reform, and clinical interventions, it asserts that the preventable causes of liver cancer can be addressed, potentially curbing the rise in preventable deaths and easing the burden on healthcare systems.